TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34459478

Group type: EXPERIMENTAL
Intervention: mHealth application for maternal health education
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional education methods (control group)
Number of subjects: 0
Study: 34398184

Group type: EXPERIMENTAL
Intervention: Gain-framed messages
Number of subjects: 1316

Group type: EXPERIMENTAL
Intervention: Loss-framed messages
Number of subjects: 1316

Group type: EXPERIMENTAL
Intervention: Altruistic messages
Number of subjects: 1316

Group type: COMPARATOR
Intervention: Non-framed information (Control)
Number of subjects: 1316
Study: 33491314

Group type: EXPERIMENTAL
Intervention: HIIT/MICT
Number of subjects: 71

Group type: COMPARATOR
Intervention: MICT
Number of subjects: 71
Study: 34407620

Group type: EXPERIMENTAL
Intervention: Enteral ivabradine
Number of subjects: 60
Study: 32534582

Group type: EXPERIMENTAL
Intervention: Throwing exercise with TheraBand
Number of subjects: 60

Group type: COMPARATOR
Intervention: Active self‐exercise program
Number of subjects: 60
Study: 35191094

Group type: EXPERIMENTAL
Intervention: Individual clinic visits
Number of subjects: 875

Group type: COMPARATOR
Intervention: Group clinic visits
Number of subjects: 875

Group type: COMPARATOR
Intervention: Group phone visits
Number of subjects: 875
Study: 34251082

Group type: EXPERIMENTAL
Intervention: Low inferior mesenteric artery ligation
Number of subjects: 130

Group type: COMPARATOR
Intervention: High inferior mesenteric artery ligation
Number of subjects: 130
Study: 32249995

Group type: EXPERIMENTAL
Intervention: Contamination mixture method
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Outlier-robust methods
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Other robust methods
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study: 35129763

Group type: EXPERIMENTAL
Intervention: Fully digital workflow (test group)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Conventional workflow (control group)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Both workflows
Number of subjects: 18
Study: 32063397

Group type: EXPERIMENTAL
Intervention: Vestronidase alfa 4 mg/kg IV
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Vestronidase alfa
Number of subjects: 12
Study: 35617911

Group type: EXPERIMENTAL
Intervention: CBT plus standardised medical care (SMC)
Number of subjects: 368

Group type: EXPERIMENTAL
Intervention: Not receiving disability benefits, lower anxiety and/or depression scores, shorter duration, younger age at DS onset, employment, fewer symptoms, higher educational qualification, stronger belief in the diagnosis and in CBT as a 'logical' treatment
Number of subjects: 368

Group type: COMPARATOR
Intervention: Standardised medical care (SMC) alone
Number of subjects: 368
Study: 34525972

Group type: EXPERIMENTAL
Intervention: Antimicrobial stewardship intervention (provider education, clinical decision aids, audit and feedback)
Number of subjects: 1682

Group type: EXPERIMENTAL
Intervention: Antimicrobial stewardship intervention
Number of subjects: 1682

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1682
Study: 32703316

Group type: EXPERIMENTAL
Intervention: medication plus DIT
Number of subjects: 240

Group type: COMPARATOR
Intervention: medication plus active control psychotherapy
Number of subjects: 240

Group type: COMPARATOR
Intervention: medication alone
Number of subjects: 240
Study: 32029860

Group type: EXPERIMENTAL
Intervention: Semi-automated axon quantification method using freeware
Number of subjects: 1238

Group type: COMPARATOR
Intervention: Manual counting
Number of subjects: 1238
Study: 35057852

Group type: EXPERIMENTAL
Intervention: Individualized PEEP setting protocol driven by end-expiratory lung volume (EELV) measurement (IPERPEEP arm)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Standard PEEP setting to achieve a plateau pressure of 28-30 cmH2O (control arm, EXPRESS strategy)
Number of subjects: 132
Study: 34703180

Group type: EXPERIMENTAL
Intervention: Oral simvastatin (40 mg, daily) for 10 days
Number of subjects: 98

Group type: COMPARATOR
Intervention: Placebo for 10 days
Number of subjects: 98
Study: 32926010

Group type: EXPERIMENTAL
Intervention: Azithromycin (500 mg orally three times/week for 12 weeks)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 48
Study: 35088142

Group type: EXPERIMENTAL
Intervention: Primary skin closure
Number of subjects: 120

Group type: COMPARATOR
Intervention: Delayed primary skin closure
Number of subjects: 120
Study: 33520191

Group type: EXPERIMENTAL
Intervention: FDI criteria
Number of subjects: 626

Group type: COMPARATOR
Intervention: CARS criteria
Number of subjects: 626

Group type: EXPERIMENTAL
Intervention: FDI criteria
Number of subjects: 626

Group type: COMPARATOR
Intervention: CARS criteria
Number of subjects: 626
Study: 34310907

Group type: EXPERIMENTAL
Intervention: FFR-guided PCI during the index hospitalization
Number of subjects: 1545

Group type: COMPARATOR
Intervention: Initial conservative management of non-culprit lesions
Number of subjects: 1545
Study: 33228815

Group type: EXPERIMENTAL
Intervention: Combined radiomic signature
Number of subjects: 539

Group type: EXPERIMENTAL
Intervention: Radiomic nomogram incorporating combined radiomic signature, age, CT T stage, and CT N stage
Number of subjects: 539

Group type: EXPERIMENTAL
Intervention: Radiomic nomogram
Number of subjects: 539
Study: 33443465

Group type: EXPERIMENTAL
Intervention: 8-week walking training program
Number of subjects: 11
Study: 33853021

Group type: EXPERIMENTAL
Intervention: trauma-informed parenting intervention
Number of subjects: 414

Group type: COMPARATOR
Intervention: foster care services as usual
Number of subjects: 414
Study: 35933413

Group type: EXPERIMENTAL
Intervention: Empagliflozin plus evolocumab (EE)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Empagliflozin (E)
Number of subjects: 110
Study: 35829656

Group type: EXPERIMENTAL
Intervention: Bimekizumab 160 mg every 4 weeks
Number of subjects: 206
Study: 33268416

Group type: EXPERIMENTAL
Intervention: Peer co-facilitated parental engagement educational programme
Number of subjects: 50

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 50
Study: 34487146

Group type: EXPERIMENTAL
Intervention: 0.5% INU (Inulin)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 0.5% IMO (Isomalto-oligosaccharide)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Basal diet (Control)
Number of subjects: 30
Study: 32246798

Group type: EXPERIMENTAL
Intervention: IL-IL (interleave-interlink) programming paradigm
Number of subjects: 25
Study: 35575988

Group type: EXPERIMENTAL
Intervention: Respiratory Training Mask (RTM)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control Mask
Number of subjects: 11
Study: 33657293

Group type: EXPERIMENTAL
Intervention: Targeted 20% human albumin solution for up to 14 days or until discharge; median total infusion of 200 g (IQR, 140 to 280) per patient.
Number of subjects: 777

Group type: COMPARATOR
Intervention: Standard care; median total infusion of 20 g (IQR, 0 to 120) per patient.
Number of subjects: 777

Group type: EXPERIMENTAL
Intervention: Targeted albumin group
Number of subjects: 777

Group type: COMPARATOR
Intervention: Standard care group
Number of subjects: 777

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 777
Study: 32075685

Group type: EXPERIMENTAL
Intervention: Primary wound closure
Number of subjects: 0

Group type: COMPARATOR
Intervention: Secondary wound healing
Number of subjects: 0
Study: 34389257

Group type: EXPERIMENTAL
Intervention: Pharmacist-administered HPV vaccine series completion
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group completing the HPV vaccine series at their FQHC
Number of subjects: 33
Study: 34708338

Group type: EXPERIMENTAL
Intervention: H. pylori eradication therapy
Number of subjects: 202

Group type: COMPARATOR
Intervention: Standard medical treatment (SMT)
Number of subjects: 202
Study: 36127081

Group type: EXPERIMENTAL
Intervention: Ecological Momentary Intervention 'SmartSafe' in addition to treatment as usual (TAU)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as usual (TAU) with Ecological Momentary Assessment (EMA) monitoring
Number of subjects: 0
Study: 34841676

Group type: EXPERIMENTAL
Intervention: Tele-exercise classes delivered via Zoom, 60-min weekly sessions by a trained exercise therapist for 3-6 months post-surgery.
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Tele-exercise classes
Number of subjects: 12
Study: 34297072

Group type: EXPERIMENTAL
Intervention: 2004-2007 trials
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 2008-2012 trials
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Top 10% of sites for 2004-2007 trials
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Top 10% of sites for 2008-2012 trials
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Central IRB
Number of subjects: 9

Group type: COMPARATOR
Intervention: Local IRB
Number of subjects: 9
Study: 32379102

Group type: EXPERIMENTAL
Intervention: 5% monolaurin vaginal gel
Number of subjects: 109

Group type: COMPARATOR
Intervention: Vehicle placebo gel
Number of subjects: 109
Study: 35719056

Group type: EXPERIMENTAL
Intervention: Photoselective vaporization of the prostate (PVP)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Diode laser vaporization (DVP)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Thulium laser vaporization (ThuVAP)
Number of subjects: 71
Study: 33646365

Group type: EXPERIMENTAL
Intervention: PAINReportIt® (electronic pain reporting device)
Number of subjects: 178

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 178
Study: 34611113

Group type: EXPERIMENTAL
Intervention: Acute psychosocial stress test
Number of subjects: 57

Group type: COMPARATOR
Intervention: Nonstress placebo task
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Anticipatory cognitive stress appraisal
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: ACTH increases
Number of subjects: 57
Study: 34169797

Group type: EXPERIMENTAL
Intervention: Vena cava filter
Number of subjects: 240
Study: 35661029

Group type: EXPERIMENTAL
Intervention: Virtual reality combined with robot-assisted gait training with 15% weight loss (Group A)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Virtual reality combined with robot-assisted gait training with 30% weight loss (Group B)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Virtual reality combined with robot-assisted gait training with 45% weight loss (Group C)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional physical therapy (Control group)
Number of subjects: 60
Study: 34167426

Group type: EXPERIMENTAL
Intervention: Ambulatory hysteroscopy (AH)
Number of subjects: 329

Group type: COMPARATOR
Intervention: Hysteroscopy under general anaesthesia (GA)
Number of subjects: 329
Study: 32114892

Group type: EXPERIMENTAL
Intervention: Serum YKL-40
Number of subjects: 2200

Group type: COMPARATOR
Intervention: Standard predictors
Number of subjects: 2200

Group type: EXPERIMENTAL
Intervention: Serum YKL-40 added as a predictor
Number of subjects: 2200
Study: 36042436

Group type: EXPERIMENTAL
Intervention: Carbohydrate loading according to the Enhanced Recovery After Surgery (ERAS) protocol
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group (fasting from midnight)
Number of subjects: 66
Study: 34274907

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control (0.9% sodium chloride)
Number of subjects: 56
Study: 35807797

Group type: EXPERIMENTAL
Intervention: Mediterranean diet supplemented with almonds (MDSA)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Usual dietary pattern (Control)
Number of subjects: 38
Study: 32332635

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional treatment measures
Number of subjects: 60
Study: 615988346

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (100 mg/mL)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 36254732

Group type: EXPERIMENTAL
Intervention: Classic interval (CI) - surgery within 8 weeks after CRT
Number of subjects: 350

Group type: COMPARATOR
Intervention: Long interval (LI) - surgery after more than 8 weeks after CRT
Number of subjects: 350
Study: 35714163

Group type: EXPERIMENTAL
Intervention: Lacticaseibacillus rhamnosus HA‐114 supplementation
Number of subjects: 152

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 152
Study: 33549260

Group type: EXPERIMENTAL
Intervention: Published RCTs (638 trials, 93.3%)
Number of subjects: 434610

Group type: COMPARATOR
Intervention: Unpublished RCTs (46 trials, 6.7%)
Number of subjects: 434610

Group type: COMPARATOR
Intervention: All unpublished trials
Number of subjects: 434610
Study: 33279855

Group type: EXPERIMENTAL
Intervention: ADT + RT70
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: ADT + DERT76
Number of subjects: 600

Group type: COMPARATOR
Intervention: DERT76
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: RT 70 Gy
Number of subjects: 600

Group type: COMPARATOR
Intervention: RT 76 Gy
Number of subjects: 600
Study: 32448796

Group type: EXPERIMENTAL
Intervention: Computerised decision-support tool to assist with antidepressant choices
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 0
Study: 32380566

Group type: EXPERIMENTAL
Intervention: Retosiban
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120

Group type: COMPARATOR
Intervention: Atosiban
Number of subjects: 120
Study: 33075789

Group type: EXPERIMENTAL
Intervention: Intravenous tramadol (100 mg in 100 mL normal saline over 10 min)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Intravenous paracetamol (1 g in 100 mL normal saline over 10 min)
Number of subjects: 100
Study: 36375187

Group type: EXPERIMENTAL
Intervention: High thoracic-ESPB
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Suprascapular nerve block (SSNB)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 96
Study: 33728717

Group type: EXPERIMENTAL
Intervention: Tanezumab 2.5 mg
Number of subjects: 849

Group type: EXPERIMENTAL
Intervention: Tanezumab 5 mg
Number of subjects: 849
Study: 33060498

Group type: EXPERIMENTAL
Intervention: Acupressure applied to HE‐7 acupuncture points for 10 minutes before surgery
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group subjected to hospital protocol
Number of subjects: 82
Study: 35409815

Group type: EXPERIMENTAL
Intervention: Centre-based exercise-training program (eight weeks, three times per week)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Maintain daily habits
Number of subjects: 40
Study: 33529168

Group type: EXPERIMENTAL
Intervention: High residual C-peptide concentration (>0.2 nmol/L)
Number of subjects: 944

Group type: EXPERIMENTAL
Intervention: Intermediate residual C-peptide concentration (>0.03 to ≤0.2 nmol/L)
Number of subjects: 944

Group type: EXPERIMENTAL
Intervention: Low residual C-peptide concentration (≥ 0.003 to ≤0.03 nmol/L)
Number of subjects: 944

Group type: EXPERIMENTAL
Intervention: No residual C-peptide concentration (<0.003 nmol/L)
Number of subjects: 944

Group type: EXPERIMENTAL
Intervention: Responders (with residual C-peptide)
Number of subjects: 944

Group type: EXPERIMENTAL
Intervention: Nonresponders (no residual C-peptide)
Number of subjects: 944
Study: 33457410

Group type: EXPERIMENTAL
Intervention: Knowledge of modern family planning methods
Number of subjects: 577

Group type: EXPERIMENTAL
Intervention: Husband approval
Number of subjects: 577

Group type: EXPERIMENTAL
Intervention: Couple's discussion
Number of subjects: 577

Group type: EXPERIMENTAL
Intervention: Male involvement in decisions about family planning
Number of subjects: 577

Group type: EXPERIMENTAL
Intervention: Desire for additional child
Number of subjects: 577

Group type: EXPERIMENTAL
Intervention: Previous use of contraception
Number of subjects: 577
Study: 35486088

Group type: EXPERIMENTAL
Intervention: Misoprostol tablets (test product)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Cytotec (200 μg) (reference product)
Number of subjects: 48
Study: 34347008

Group type: EXPERIMENTAL
Intervention: 12-week moderate-intensity aerobic exercise training program (exercise group)
Number of subjects: 60
Study: 34596484

Group type: EXPERIMENTAL
Intervention: Mirabegron 50 mg OD
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Solifenacin 5 mg OD
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.4 mg OD
Number of subjects: 150
Study: 34772982

Group type: EXPERIMENTAL
Intervention: NMES (Neuromuscular Electrical Stimulation) applied bilaterally at thigh and calves for 40 min during each hemodialysis session, three times a week for 1 month
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (no NMES)
Number of subjects: 21
Study: 36110857

Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy (ART) during primary HIV infection (PHI)
Number of subjects: 51
Study: 34375514

Group type: EXPERIMENTAL
Intervention: L. edodes bars (shiitake bars)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study: 36889453

Group type: EXPERIMENTAL
Intervention: Symptom Care at Home (SCH) intervention (n = 144)
Number of subjects: 298

Group type: COMPARATOR
Intervention: Usual hospice care (UC) (n = 154)
Number of subjects: 298
Study: 32949011

Group type: EXPERIMENTAL
Intervention: L. sakei proBio65 live cells (1 × 10^10 cells/day for 12 weeks)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: L. sakei proBio65 dead cells (1 × 10^10 cells/day for 12 weeks)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: L. sakei proBio65 live cells
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: L. sakei proBio65 dead cells
Number of subjects: 90
Study: 33172525

Group type: EXPERIMENTAL
Intervention: Self-education and infographic material, plus 45 text messages via SMS.
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group received self-education after the intervention at 3 months.
Number of subjects: 47
Study: 35961661

Group type: EXPERIMENTAL
Intervention: Surgery rotation
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Procedural rotation (emergency medicine, obstetrics and gynecology)
Number of subjects: 115

Group type: COMPARATOR
Intervention: No procedural rotation
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Interest in surgical discipline
Number of subjects: 115
Study: 33657295

Group type: EXPERIMENTAL
Intervention: Nivolumab plus Cabozantinib
Number of subjects: 651

Group type: COMPARATOR
Intervention: Sunitinib
Number of subjects: 651
Study: 33168406

Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway (LMA)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Endotracheal Tube (ETT)
Number of subjects: 100
Study: 35209911

Group type: EXPERIMENTAL
Intervention: HIIT/MICT
Number of subjects: 73

Group type: COMPARATOR
Intervention: MICT
Number of subjects: 73
Study: 33071178

Group type: EXPERIMENTAL
Intervention: Metabolic bariatric surgery (MBS)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Medical therapy (metformin alone or in combination with rosiglitazone or intensive lifestyle intervention)
Number of subjects: 93
Study: 34190967

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 3377

Group type: COMPARATOR
Intervention: Prasugrel
Number of subjects: 3377
Study: 33741847

Group type: EXPERIMENTAL
Intervention: Everolimus with reduced Tacrolimus (EVR+rTAC)
Number of subjects: 772

Group type: COMPARATOR
Intervention: Standard Tacrolimus (sTAC)
Number of subjects: 772
Study: 36031464

Group type: EXPERIMENTAL
Intervention: Midcarpal arthroscopy
Number of subjects: 14

Group type: COMPARATOR
Intervention: Radiocarpal arthroscopy
Number of subjects: 14
Study: 33754155

Group type: EXPERIMENTAL
Intervention: AI-assisted contouring
Number of subjects: 9

Group type: COMPARATOR
Intervention: Unassisted contouring
Number of subjects: 9
Study: 33421652

Group type: EXPERIMENTAL
Intervention: Slow-motion video demonstration
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Real-time video demonstration
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Combination of slow-motion and real-time video demonstration
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 51
Study: 32969161

Group type: EXPERIMENTAL
Intervention: Vacuum-assisted excisional biopsy (VAEB)
Number of subjects: 299

Group type: EXPERIMENTAL
Intervention: Open-surgical-excisional biopsy
Number of subjects: 299

Group type: COMPARATOR
Intervention: Pre-operative diagnosis of papillary lesion with atypia
Number of subjects: 299

Group type: COMPARATOR
Intervention: Pre-operative diagnosis of flat epithelial atypia
Number of subjects: 299

Group type: COMPARATOR
Intervention: Pre-operative diagnosis of atypical ductal hyperplasia
Number of subjects: 299

Group type: COMPARATOR
Intervention: Pre-operative diagnosis of lobular carcinoma in situ (LCIS)/atypical lobular hyperplasia with calcification
Number of subjects: 299

Group type: COMPARATOR
Intervention: Pre-operative diagnosis of papillary lesion without atypia
Number of subjects: 299

Group type: COMPARATOR
Intervention: Pre-operative diagnosis of radial scar
Number of subjects: 299

Group type: COMPARATOR
Intervention: Pre-operative diagnosis of classical LCIS without calcification
Number of subjects: 299

Group type: COMPARATOR
Intervention: Pre-operative diagnosis of mucocoele-like lesion
Number of subjects: 299
Study: 35292978

Group type: EXPERIMENTAL
Intervention: Aerobic exercise intervention (4 physical education lessons per week)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Cognitively demanding exercise intervention (4 physical education lessons per week)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control group (regular physical education program of 2 lessons per week)
Number of subjects: 93
Study: 33846075

Group type: EXPERIMENTAL
Intervention: Screening for PAD
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low dose rivaroxaban
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Screening for PAD (5 year follow up)
Number of subjects: 0
Study: 32100628

Group type: EXPERIMENTAL
Intervention: fast‐eccentric BP
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: concentric‐only BP
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: controlled‐eccentric BP
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: experienced participants
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: non‐experienced participants
Number of subjects: 30
Study: 35275541

Group type: EXPERIMENTAL
Intervention: Kundalini Yoga and Kirtan Kriya (KY+KK) for 12 weeks
Number of subjects: 22

Group type: COMPARATOR
Intervention: Memory Enhancement Training (MET)
Number of subjects: 22
Study: 34106027

Group type: EXPERIMENTAL
Intervention: Tai Chi
Number of subjects: 92

Group type: COMPARATOR
Intervention: Mind-Body Breathing (MBB)
Number of subjects: 92